MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Sponsored by Penumbra, Inc.
Lightning Flash™: The Most Powerful and Advanced Mechanical Thrombectomy System for PE and Venous Thrombus
With Patrick Muck, MD, RVT, FACS; Noor Ahmad, MD; Adel Barkat, MD; Sam Tyagi, MD; Nancy Clark, MD; and Varshana Gurusamy, MD
The Spectrum of PFO Closure Devices
A closer look at current technology as the indications for PFO closure become clearer.
By Narbeh Melikian, BSc, MB BS, MD, FRCP, and Philip A. MacCarthy, BSc, MB BCh, PhD, FRCP
Manual Thrombus Aspiration in STEMI Treatment
Examining the role of thrombus aspiration as an adjunct to mechanical reperfusion.
By Yalcin Hacioglu, MD; Zubair Ahmed, MD; Abdul Hakeem, MD; and Barry F. Uretsky, MD
Embolic Protection During TAVR: Where Do We Go After PROTECTED TAVR?
Where we stand with data on cerebral embolic protection and a discussion of current and future devices for reducing the burden of stroke during TAVR.
By Amit N. Vora, MD, MPH; Yousif Ahmad, MD, PhD; and Alexandra Lansky, MD
CMS and AMA Initiatives Will Help Providers Prepare for ICD-10
July 6, 2015—The Centers for Medicare & Medicaid Services (CMS) and the American Medical Association (AMA) announced efforts to continue to help physicians get ready ahead of the October 1 deadline when the nation switches its International Classification of Diseases (ICD) coding for medical diagnoses and inpatient hospital procedures from ICD-9 to ICD-10.
Physiology-Stratified Analysis of ORBITA Presented at EuroPCR
May 23, 2018—Results from the physiology-stratified analysis of ORBITA were presented at EuroPCR 2018, held May 21–25 in Paris, France by Rasha Al-Lamee, MD, Interventional Cardiology Consultant and Principal Investigator for ORBITA.
Five-Year Data Published for Terumo's Nobori DES With Biodegradable Polymer
December 23, 2014—Bernard Chevalier, MD, et al published the 5-year clinical outcome data of the Nobori coronary drug-eluting stent (DES) system (Terumo Interventional Systems) in the treatment of patients with coronary artery disease.
Studies Address Improving Door-to-Balloon Times for STEMI Patients
September 18, 2013—B.
An Interview With Ralph G. Brindis, MD
Dr. Brindis discusses updated guidelines for DAPT, accreditation, the development of a national medical device postmarket surveillance system, and more.
Femoral and Apical Closure Devices for TAVR
Closure devices in various stages of development that may help reduce access-related complications.
By Jonathon White, MD, and Mathew Williams, MD
DCBs for De Novo Lesions and ISR: Why, When, and How
A practical framework for adopting a metal-sparing PCI strategy across established and emerging coronary indications.
By Matteo Sturla, MD; Mauro Gitto, MD; and Pier Pasquale Leone, MD, MSc
Ask the Experts: Is Patent Hemostasis After Radial Access Truly Valuable?
With Ian C. Gilchrist, MD, FSCAI; Kimberly Skelding, MD, FACC, FAHA, FSCAI; and Jennifer A. Tremmel, MD, MS
Interatrial Shunts: A Promising Therapy for HFpEF or Disappointing Mirage?
Highlighting the potential of interatrial shunting in a population with limited therapeutic options.
By Preethi Pirlamarla, MD, and Vikrant Jagadeesan, MD
Sponsored by CeloNova BioSciences, Inc.
Clinical Decision-Making for PCI Patients During the COVID-19 Pandemic
With Aloke Finn, MD; Rajiv Jauhar, MD, FACC, FSCAI; and S. Jay Mathews, MD, MS, FACC
When It Comes to Open-Door Access, Culture Matters
A proper foundation is necessary for access improvement efforts to be successful.
By Joel Sauer, MBA, and Ginger Biesbrock, PA-C, MPH, MPAS, AACC
A Cardiogenic Shock Challenge: Achieving 24-Hour Door-to-Lactate Clearance
SCAI President Srihari S. Naidu, MD, is challenging the interventional cardiology field and all members of the shock team to achieve a door-to-lactate clearance of 24 hours to improve cardiogenic shock outcomes.
With Srihari S. Naidu, MD, MSCAI
Door-to-Balloon Times Show Dramatic Improvement in the US
August 22, 2011—The American Heart Association (AHA) announced findings from a study showing that > 90% of the ST-elevated myocardial infarction patients who require emergency angioplasty are treated within the recommended 90 minutes from hospital arrival compared to 5 years before the period analyzed in the study, when less than half of these patients were treated in this timeframe.
Among Frailty Indexes, Poor Mobility Shown to Be Best Predictor of Adverse Outcomes in TAVR
July 10, 2015—James Cockburn, MD, et al published findings from an examination of multiple frailty indexes as markers of performance to see whether they predict outcomes both in the shorter (30 days) and longer (5 years) terms in patients who have undergone transcatheter aortic valve replacement (TAVR).
Study Shows Premature Clopidogrel Discontinuation After DES in a Poor, Urban Patient Population
December 7, 2015—Noting that premature clopidogrel discontinuation is an important cause of stent thrombosis, myocardial infarction, and death after drug-eluting stent (DES) placement, Houman Khalili, MD, et al conducted an investigation of this problem in a large, urban safety-net hospital.
An Interview With James C. Blankenship, MD
The newly inducted President of SCAI discusses what's ahead for the society during the next year, challenges with current health care policy, and why he's an enthusiastic radialist.
